Close Menu

More articles about Neurological & Psychological Disorders

A European consortium involving more than a dozen research institutions will use NimbleGen arrays in their study of neuromuscular disorder genetics.

Multiple Personalities

Premium

With its hybrid-core tool, an innovative hardware vendor gives clusters a run for their money — while promising to save yours.

The company will use the funds to develop protein-based Alzheimer's diagnostics.

Already, the promise of synthetic biology is being realized as this level of engineering is brought into drug development. GT looks into synthetic biology drugs in the pipeline and where this field is heading.

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

The $3 million Stem Cell Commercialization Facility will open in June within 2,508 square feet of TechOne, the 100,000-square-foot first building of up to three that are planned to comprise the tech park, called TechTown.

Patent Watch: Feb 20, 2009

Premium

US Department of Veterans Affairs, Meso Scale Technologies, and Acadia Pharmaceuticals Awarded US Patents

IP Update: Feb 19, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

NHLBI plans to launch next month the prospectively designed, randomized-controlled study, called Clarification of Optimal Anticoagulation through Genetics trial, which will follow 1,200 patients to see if PGx-guided dosing is clinically useful.

New Products: Feb 6, 2009

Premium

Aruna Biomedical

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

Industry Briefs: Feb 5, 2009

Premium

Thermo Fisher Scientific, Agilent, NHLBI, Journal of Proteome Research, Roche, Fluorotechnics, and more.

Snippets: Feb 4, 2009

Premium

National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Myriad attributed a 58 percent jump in molecular diagnostics revenues to an expansion of its sales force and an ongoing DTC campaign.

The exclusive pact gives Transgenomic rights to a diagnostic test for likelihood of neurodegenerative diseases.

Pages

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

The founder of MeTooSTEM, BethAnn McLaughlin, created a Twitter account purported to be that of an LGBTQ Native American professor at Arizona State University, the New York Times writes.

Novavax reports its candidate SARS-CoV-2 vaccine leads to immune responses, according to the Sydney Morning Herald.

Gene length is associated with lifespan in a comparative genomics study appearing in the Proceedings of the National Academy of Sciences that draws on the whale shark genome.